Krishna Institute of Medical Sciences Limited (KIMS) announced the outcome of its Board Meeting held on February 6, 2026. The Board approved the unaudited standalone and consolidated financial results for the third quarter and nine months ended December 31, 2025, along with the unmodified Limited Review Reports from statutory auditors M/s. S.R. Batliboi & Co. LLP. The meeting commenced at 02:30 PM and concluded at 06:00 PM. Additionally, the Board accorded its consent to increase the limit for the acquisition of shares in its material subsidiary, Sarvejana Healthcare Private Limited (Sunshine Hospital), by up to ₹100 Crores. This acquisition will be undertaken in one or more tranches from minority shareholders. Sunshine Hospital, in which KIMS currently holds a 75.53% stake, is in the healthcare industry and had a turnover of ₹597.00 Crores for the financial year ended March 31, 2025. The investment is intended as a strategic move to further enhance KIMS's shareholding. The financial results will also be published in newspapers as per SEBI regulations. The disclosures related to the acquisition are available on the company's website.
